Hajiev, Saur
Allara, Elias
Motedayеn Aval, Leila
Arizumi, Tadaaki
Bettinger, Dominik
Pirisi, Mario
Rimassa, Lorenza
Pressiani, Tiziana
Personeni, Nicola
Giordano, Laura
Kudo, Masatoshi
Thimme, Robert
Park, Joong-Won
Taddei, Tamar H.
Kaplan, David E.
Ramaswami, Ramya
Pinato, David J.
Sharma, Rohini http://orcid.org/0000-0003-2441-549X
Article History
Received: 6 May 2020
Revised: 15 September 2020
Accepted: 25 September 2020
First Online: 19 October 2020
Change Date: 3 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published: https://doi.org/10.1038/s41416-020-01241-5
Ethics approval and consent to participate
: The study protocol was approved by the Yorkshire & The Humber - Sheffield Research Ethics Committee in the UK (Reference 17/YH/0015), as well as the institutional review boards in each participating institution (Supplementary Information InternalRef removed). The study was conducted in accordance with the Declaration of Helsinki (update 2004). Subjects provided informed consent in centres with prospective data collection, and in centres with retrospective data collection consent was waived by the respective institutional review boards.
: All authors have read the paper and consent to publication.
: Data are available from individual institutions.
: L.R.: consulting and advisory role: Amgen, ArQule, Basilea, Baxter, Bayer, Celgene, Eisai, Exelixis, Hengrui, Incyte, Ipsen, Italfarmaco, Lilly, MSD, Roche, Sanofi, Sirtex Medical; honoraria and lectures: AbbVie, AstraZeneca, Gilead; travel expenses: ArQule, Ipsen. D.B.: consulting and advisory: Bayer Healthcare, Boston Scientific; honoria and lectures: Falk Foundation. N.P.: consulting and advisory role: Amgen, Merck Serono, Servier; lectures: AbbVie, Gilead, Lilly; travel expenses: Amgen, ArQule. D.J.P.: research funding: MSD, Bristol-Myers Squibb, Franco Trevisani; consulting and advisory role: Bayer AG, Alfasigma, Bristol-Myers Squibb; lectures: Bayer AG, Roche, Falk Foundation; travel, accommodations, expenses: Bayer AG. R.S.: research funding: Incyte, AAA; consulting and advisory role: Esai, Roche, Bayer AG, SIRTEX; lectures: Bayer AG, Falk Foundation. No other author has any conflict of interest to declare.
: No funding was received for this study.